Works matching IS 18607179 AND DT 2022 AND VI 17 AND IP 21
Results: 11
Front Cover: Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives (ChemMedChem 21/2022).
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200567
- By:
- Publication type:
- Article
GluN2A‐Selective NMDA Receptor Antagonists: Mimicking the U‐Shaped Bioactive Conformation of TCN‐201 by a [2.2]Paracyclophane System.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200484
- By:
- Publication type:
- Article
Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200476
- By:
- Publication type:
- Article
Frontiers in Medicinal Chemistry 2022 Goes Virtual.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200419
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage Response.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200415
- By:
- Publication type:
- Article
Design, Synthesis, and in Vitro Evaluation of 4‐(4‐Hydroxyphenyl)piperazine‐Based Compounds Targeting Tyrosinase.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200305
- By:
- Publication type:
- Article
Fluorinated Cycloalkyl Building Blocks for Drug Discovery.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200365
- By:
- Publication type:
- Article
From DC18 to MR07: A Metabolically Stable 4,4′‐Oxybisbenzoyl Amide as a Low‐Nanomolar Growth Inhibitor of P. falciparum.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200355
- By:
- Publication type:
- Article
Isolation of a Natural Killer Group 2D Small‐Molecule Ligand from DNA‐Encoded Chemical Libraries.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200350
- By:
- Publication type:
- Article
Antigiardial Activity of Novel Guanidine Compounds.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200341
- By:
- Publication type:
- Article
Piperazine‐Modified Ketoconazole Derivatives Show Increased Activity against Fungal and Trypanosomatid Pathogens.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200385
- By:
- Publication type:
- Article